whatshot

CLYM   $10.8801  1.59% Market Open

Climb Bio, Inc.
show_chart Advanced Chart of CLYM

Current temperature: 11.60
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 14
Target Price Mean 26.21
Mean unverified/preliminary 26.21 / 26.21
Target Price Low / High 10.94 / 40.00
Median / STD DEV 25.00 / 7.28
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy ActivelyBuy
rsi ActivelyBuy Buy None
macd None None None
stoch None None None
ma20 Sell Sell Sell
ma50 None None None
ma100 None Buy ActivelyBuy
Candlestick PatternSept. 24, 2026 Bearish Three Outside Down - pattern is a made up of three candlesticks. A white candlestick appears on the first day in a uptrend. The second day body engulfs the white body of the first day. A black candlestick on the third day with a lower close than the second day. Considered to be a bearish reversal pattern.
ISIN US28658R1068
ceo Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Website https://eliemtx.com
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.